Ensysce Biosciences Stock Target Price and Analyst Consensus
| ENSC Stock | USD 0.49 0.01 2.00% |
The current analyst and expert consensus on Ensysce Biosciences is Buy, with no strong buy opinions. The current projected Ensysce Biosciences target price consensus is 13.72 with 1 analyst opinions. Check out Macroaxis Advice on Ensysce Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.The most common way Ensysce Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Ensysce Biosciences executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Ensysce Biosciences. We encourage you to use your own analysis of Ensysce Biosciences to validate this buy or sell advice. Ensysce Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Ensysce Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 22.9624.
Lowest Forecast 12.49 | Highest Forecast 15.23 | Target Price 13.72 |
Ensysce |
It's important to approach Ensysce Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Ensysce Biosciences price targets
Ensysce Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Ensysce Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Ensysce Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ensysce Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Ensysce Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ensysce Biosciences is a key component of Ensysce Biosciences valuation and have some predictive power on the future returns of a Ensysce Biosciences.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Social Domain Invested few shares | |
 | Blockchain Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Investor Favorites Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | FinTech Invested over 40 shares | |
 | Artificial Intelligence Invested few shares | |
Check out Macroaxis Advice on Ensysce Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Please note, the presentation of Ensysce Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ensysce Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ensysce Biosciences' management manipulating its earnings.